These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22504300)

  • 1. Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing.
    Rigo F; Hua Y; Chun SJ; Prakash TP; Krainer AR; Bennett CF
    Nat Chem Biol; 2012 Apr; 8(6):555-61. PubMed ID: 22504300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense therapeutics: New ways to nudge splicing.
    Eperon I
    Nat Chem Biol; 2012 May; 8(6):507-8. PubMed ID: 22596201
    [No Abstract]   [Full Text] [Related]  

  • 3. Antisense oligonucleotides and spinal muscular atrophy: skipping along.
    Burghes AH; McGovern VL
    Genes Dev; 2010 Aug; 24(15):1574-9. PubMed ID: 20679391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-mRNA Splicing Modulation by Antisense Oligonucleotides.
    Singh NN; Luo D; Singh RN
    Methods Mol Biol; 2018; 1828():415-437. PubMed ID: 30171557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
    Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.
    Karras JG; McKay RA; Dean NM; Monia BP
    Mol Pharmacol; 2000 Aug; 58(2):380-7. PubMed ID: 10908306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides.
    Scharner J; Ma WK; Zhang Q; Lin KT; Rigo F; Bennett CF; Krainer AR
    Nucleic Acids Res; 2020 Jan; 48(2):802-816. PubMed ID: 31802121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.
    d'Ydewalle C; Ramos DM; Pyles NJ; Ng SY; Gorz M; Pilato CM; Ling K; Kong L; Ward AJ; Rubin LL; Rigo F; Bennett CF; Sumner CJ
    Neuron; 2017 Jan; 93(1):66-79. PubMed ID: 28017471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.
    Singh NN; Seo J; Rahn SJ; Singh RN
    PLoS One; 2012; 7(11):e49595. PubMed ID: 23185376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of SMN trans-splicing through the analysis of SMN introns.
    Shababi M; Lorson CL
    J Mol Neurosci; 2012 Mar; 46(3):459-69. PubMed ID: 21826391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.
    Singh NN; Lee BM; DiDonato CJ; Singh RN
    Future Med Chem; 2015; 7(13):1793-808. PubMed ID: 26381381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U2AF65-Dependent SF3B1 Function in SMN Alternative Splicing.
    Choi N; Liu Y; Oh J; Ha J; Zheng X; Shen H
    Cells; 2020 Dec; 9(12):. PubMed ID: 33317029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
    Hofmann Y; Wirth B
    Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense-mediated exon inclusion.
    Hua Y; Krainer AR
    Methods Mol Biol; 2012; 867():307-23. PubMed ID: 22454070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense methods to modulate pre-mRNA splicing.
    Seo J; Ottesen EW; Singh RN
    Methods Mol Biol; 2014; 1126():271-83. PubMed ID: 24549671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Evaluation of Antisense-Mediated Exon Inclusion for Spinal Muscular Atrophy.
    Touznik A; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():439-454. PubMed ID: 30171558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using mini-genes to identify factors that modulate alternative splicing.
    Morse R; Todd AG; Young PJ
    Methods Mol Biol; 2012; 867():349-62. PubMed ID: 22454072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA.
    Zhang Z; Kelemen O; van Santen MA; Yelton SM; Wendlandt AE; Sviripa VM; Bollen M; Beullens M; Urlaub H; Lührmann R; Watt DS; Stamm S
    J Biol Chem; 2011 Mar; 286(12):10126-36. PubMed ID: 21220421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements.
    Recinos Y; Ustianenko D; Yeh YT; Wang X; Jacko M; Yesantharao LV; Wu Q; Zhang C
    Nat Commun; 2024 May; 15(1):3839. PubMed ID: 38714659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.